<DOC>
	<DOCNO>NCT00591006</DOCNO>
	<brief_summary>The purpose research determine patient receive phenytoin ( also commonly know Dilantin ) take corticosteroid show less memory impairment hypomanic symptom ( feeling agitation , overexcitement hyperactivity ) receive placebo ( inactive substance ) . This research also seek determine patient take phenytoin corticosteroid show activity area brain involved memory receive placebo . This research do increase level cortisol ( body 's natural corticosteroid ) body frequently associate forgetfulness , intervention may prevent reverse effect great importance .</brief_summary>
	<brief_title>Phenytoin Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes</brief_title>
	<detailed_description>Introduction aim : Stress corticosteroid exposure associate change human animal hippocampus . In animal , phenytoin prevents dendritic change hippocampus secondary corticosterone . We propose use functional magnetic resonance imaging ( fMRI ) explore effect 3-days exposure placebo , hydrocortisone , phenytoin hydrocortisone plus phenytoin hippocampal activation . If phenytoin attenuates effect hydrocortisone , use model system explore potential neuroprotective agent CONCISE SUMMARY OF PROJECT : Sixteen healthy participant , one-hour imaging session , receive structural magnetic resonance imaging ( MRI ) , magnetic resonance spectroscopy ( MRS ) fMRI scan four separate time 21 day washout study drug exposure crossover design . Prior scan participant receive placebo + placebo , phenytoin + placebo , hydrocortisone + placebo , hydrocortisone + phenytoin random fashion . Thus , participant receive four possible study drug combination random order extend drug washout exposure . Hippocampal activation , volume biochemistry , well mood memory assess . The figure Appendix I illustrate study design . All participant complete University Texas ( UT ) Southwestern ( UTSW ) Institutional Review Board ( IRB ) approve informed consent process give write consent participate prior study entry . At first screen visit , demographic information complete medical psychiatric history obtain . The Structured Clinical Interview DSM-IV ( SCID ) ( First et al 1995 ) use rule exclusionary psychiatric illness . Mood assess Hamilton Rating Scale Depression ( HRSD ) , Young Mania Rating Scale ( YMRS ) , Activation ( ACT ) subscale ISS . Cognition assess Rey Auditory Verbal Learning Test ( RAVLT ) ( declarative memory-hippocampus ) , Digit Span Backwards , two computer test — Sternberg Memory Task ( SMT , declarative memory-hippocampus ) ( Sternberg 1969 ) , Running Memory Continuous Performance Task ( RMCPT , work memory-prefrontal cortex ) ( Baddeley 1986 ) . Alternative version test use throughout study minimize learn effect . For subject successfully pass screen , fMRI session schedule , ask return 4 day prior first scan . If subject feel uncomfortable answer question questionnaire screen visit , refuse , remove study . If psychological disorder diagnose stage ( e.g. , mood disorder depression ) , subject remove study refer either Parkland hospital private psychiatrist base insurance coverage evaluation treatment . If late stage abnormality uncover imaging , subject notify immediately . Subjects provide referral either Parkland Hospital different facility base insurance coverage . With subject 's consent , also notify primary physician . Pregnancy test obtain female baseline prior start new medication cycle ensure pregnant woman participate study ( 5 time total study ) . One day prior study drug course , mood assess HRSD , YMRS , ACT subscale Internal State Scale , cognition assess Sternberg Memory Task . Three day prior image , participant take two capsule contain phenytoin tablet ( 100 mg ) identical placebo mouth 0900 hour 2100 hour ( 400 mg/day ) total three day last dose 0900 hour day image ( 7 dos total ) . Beginning two day prior image ( day initiate phenytoin placebo ) , participant begin take 4 tablet contain hydrocortisone ( 20 mg ) placebo also 0900 hour 2100 hour ( 160 mg/day ) last dose 0900 hour day image ( 5 dos total ) . The dos select achieve low therapeutic blood level phenytoin stress level cortisol . Newcomer et al . ( 1999 ) use dose hydrocortisone healthy control . The imaging perform approximately 1300 hour . Imaging perform three day exposure study medication . Mood assessment SMT conduct baseline prior course study medication ( day medication course begin day neuroimaging ) . The SMT large number equivalent version thus administer numerous time . By administer prior exposure study drug determine whether memory , expect , return baseline washout period . Other cognitive test include RAVLT , Digits Backwards , RMCPT perform course study medication . Cognitive testing perform prior receive study medication avoid multiple test short period time unnecessary give baseline placebo data use comparison . Monitoring study drug level : Blood drawn baseline ( approximately 1400 hour ) assess cortisol level . Blood drawn scan ( approximately 1400 hour ) assess cortisol phenytoin level ensure adherence medication . We anticipate increase cortisol level follow administration cortisol compare baseline subject take cortisol , therapeutic level phenytoin seizure ( 10 20 mg/l ) achieve .</detailed_description>
	<mesh_term>Phenytoin</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Neuroprotective Agents</mesh_term>
	<criteria>Age 1850 year Men woman Vision correct least 2040 No tobacco use Education ≥12 year ( No GED ) History major psychiatric illness define major depressive disorder , bipolar disorder , post traumatic stress disorder , panic disorder , schizoaffective disorder , schizophrenia eat disorder History drug alcohol abuse dependence History neurological disorder include seizure , brain surgery , multiple sclerosis , Parkinson 's disease Taking central nervous system ( CNS ) act medication ( e.g . antidepressant , hypnotic ) History allergic reaction medical contraindication phenytoin hydrocortisone therapy Metal implant , claustrophobia contraindication MRI Significant medical condition ( e.g . myocardial infarction , diabetes ) Pregnant nurse woman Prisoners History mental retardation , special education class , dementia severe cognitive disorder Baseline Hamilton Rating Scale Depression Score &gt; 7 History suicide attempt History systemic corticosteroid use current inhaled corticosteroid use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Phenytoin</keyword>
	<keyword>Dilantin</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Mania</keyword>
	<keyword>Cognition</keyword>
	<keyword>Mood</keyword>
	<keyword>Memory</keyword>
	<keyword>Hydrocortisone</keyword>
	<keyword>Healthy Controls</keyword>
	<keyword>MRI</keyword>
	<keyword>hippocampal activation</keyword>
</DOC>